All Stories

  1. The Need to Promote Olfactory Health in Public Health Agendas Across the Globe
  2. Endoscopic Management of Sinus Neoplasia: An Experience of a Dedicated Sinus Centre in Image-Guided Surgery of Inverted Papillomata
  3. A trial comparing sinus surgery and antibiotics in adults with chronic rhinosinusitis
  4. The need to promote smell health across the globe
  5. Exploring barriers to seeking support for Smell and Taste Disorders (SATDs) amongst minority communities in the UK
  6. Gustatory dysfunction in dementia and cognitive decline
  7. Olfactory loss and dysfunction in dementia and cognitive decline
  8. A New Approach to Dementia
  9. \fancyhead [R] Smell and Taste Disorder Impact on Eating Habits: a cross-sectional observational study
  10. The Development and Validation of the Smell‐Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders
  11. Epidemiology of Cholesteatoma in the UK Biobank
  12. British Skull Base Society Consensus on Vestibular Schwannoma Surveillance
  13. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control
  14. Epidemiology of Cholesteatoma in the UK Biobank
  15. Smell Above All: Envisioning Smell-Centred Future Worlds
  16. Impact of olfactory disorders on personal safety and well-being: a cross-sectional observational study
  17. Evaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
  18. The Clinical Course of Paranasal Sinus Mucocoeles—A Retrospective Case Series
  19. Obesity and Olfaction
  20. Abstracts from the 56th European Society of Human Genetics (ESHG) Conference: Hybrid Posters
  21. International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction
  22. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
  23. Delivery of Topical Drugs to the Olfactory Cleft
  24. Endoscopic management of sinus neoplasia: case series of image-guided surgery of inverted papillomata and recommended best practice for managing cases.
  25. Everything smells like poo, landfill, and rotten food”: A retrospective case report using Clinical Emotional Freedom Techniques (EFT) for parosmia following COVID-19
  26. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO)
  27. Position paper on olfactory dysfunction: 2023
  28. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study
  29. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  30. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  31. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  32. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  33. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  34. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  35. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  36. Nose Gym: An Interactive Smell Training Solution
  37. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  38. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  39. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  40. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  41. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  42. The Nose and the Effects of SARS-CoV-2 Pandemic
  43. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  44. The EUFOREA pocket guide for chronic rhinosinusitis
  45. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  46. Investigations and Outcomes for Olfactory Disorders
  47. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  48. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  49. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  50. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  51. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  52. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  53. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  54. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  55. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  56. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  57. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  58. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  59. International consensus statement on allergy and rhinology: Olfaction
  60. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  61. Interventions for the treatment of persistent post-viral olfactory dysfunction
  62. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  63. Olfaction and CSF Leak
  64. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  65. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  66. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  67. Barriers to effective health care for patients who have smell or taste disorders
  68. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  69. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  70. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  71. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  72. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  73. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  74. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  75. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  76. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  77. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  78. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  79. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  80. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  81. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  82. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  83. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  84. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  85. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  86. Patient Experiences of Postinfectious Olfactory Dysfunction
  87. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  88. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  89. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  90. Comparison of COVID-19 and common cold chemosensory dysfunction
  91. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  92. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  93. Patient Experiences of Post-Infectious Olfactory Dysfunction
  94. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  95. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  96. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  97. Olfactory Loss of Function as a Possible Symptom of COVID-19
  98. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  99. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  100. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  101. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  102. Qualitative Olfactory Disorders: Patient experiences and self-management
  103. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  104. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  105. Parosmia is associated with relevant olfactory recovery after olfactory training
  106. The impact of patients losing their sense of smell
  107. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  108. Cholesteatoma and family history: An international survey
  109. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  110. Biologics for chronic rhinosinusitis
  111. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  112. Biologics for chronic rhinosinusitis
  113. An unmet need: Patients with smell and taste disorders
  114. 139 Risk of parkinson’s in idiopathic anosmia
  115. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  116. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  117. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  118. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  119. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  120. What is the most appropriate treatment for chronic rhinosinusitis?
  121. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  122. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  123. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  124. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  125. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  126. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  127. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  128. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  129. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  130. Wooden spatula sinusitis following maxillary expansion surgery
  131. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  132. Topical and systemic antifungal therapy for chronic rhinosinusitis
  133. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  134. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  135. Saline irrigation for allergic rhinitis
  136. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  137. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  138. Endonasal Approaches to Maxillary Sinus
  139. The use of nasal sprays and rinses in patients with chronic sinus disease
  140. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  141. Initial assessment in the management of adult epistaxis: systematic review
  142. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  143. Health care usage and quality of life reporting in chronic sinusitis patients
  144. The genetics of cholesteatoma. A systematic review using narrative synthesis
  145. Position paper on olfactory dysfunction
  146. Chronic rhinosinusitis and mood disturbance
  147. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  148. Saline irrigation for allergic rhinitis
  149. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  150. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  151. Position paper on olfactory dysfunction
  152. Chronic rhinosinusitis and mood disturbance
  153. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  154. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  155. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  156. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  157. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  158. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  159. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  160. Topical and systemic antifungal therapy for chronic rhinosinusitis
  161. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  162. SNOT-22 in a control population
  163. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  164. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  165. Genetics of Cholesteatoma Project
  166. Short-course oral steroids alone for chronic rhinosinusitis
  167. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  168. Different types of intranasal steroids for chronic rhinosinusitis
  169. Systemic and topical antibiotics for chronic rhinosinusitis
  170. Saline irrigation for chronic rhinosinusitis
  171. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  172. Chronic rhinosinusitis and mood disturbance
  173. Long term quality of life in patients with fungal sinus disease
  174. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  175. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  176. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  177. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  178. Systemic and topical antibiotics for chronic rhinosinusitis
  179. Saline irrigation for chronic rhinosinusitis
  180. Different types of intranasal steroids for chronic rhinosinusitis
  181. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  182. Short-course oral steroids alone for chronic rhinosinusitis
  183. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  184. The impact of commissioning for rhinosinusitis in England
  185. Investigation of nasal diseases
  186. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  187. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  188. Authors’ response
  189. Hyposmia
  190. Assessing the sense of smell
  191. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  192. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  193. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  194. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  195. The Impact of Olfactory Disorders in the United Kingdom
  196. Chronic Rhinosinusitis and Mood Disturbance
  197. Management of CRSwNPs Surgically
  198. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  199. SNOT-22 in a Control Population
  200. Anatomy and Physiology of the Olfactory and Gustatory Systems
  201. Cerebrospinal Fluid Rhinorrhoea
  202. Ciliary Motility Disorders
  203. Clinical Governance and Audit
  204. Complications of Sinusitis
  205. Endoscopic Sinus Surgery and Complications
  206. Epistaxis
  207. European Position Paper on Rhinosinusitis and Nasal Polyps
  208. Facial Flaps, Scars, and Keloids
  209. Facial Fractures and Swelling
  210. Fungal Sinus Disease
  211. Headache and Facial Pain
  212. Medical Statistics
  213. Microbiology of ENT
  214. Olfactory and Gustatory Disorders
  215. Sinonasal Anatomy and Physiology
  216. Tumours of the Nose and Paranasal Sinuses
  217. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  218. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  219. Unilateral cacosmia: a presentation of maxillary fungal infestation
  220. When mealtime is the most dreaded moment of your day
  221. Pneumatisation of turbinates and paranasal sinuses in children: case report
  222. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  223. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  224. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  225. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  226. A useful tool - systematic checklist for evaluating sinus scans
  227. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  228. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  229. Allergic fungal rhinosinusitis - a new staging system
  230. Allergic fungal rhinosinusitis - a new staging system
  231. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  232. Selecting the Best Approach to the Frontal Sinus
  233. Nanomedicine in otorhinolaryngology: what does the future hold?
  234. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  235. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  236. Tumefactive fibroinflammatory lesion of the frontal sinus
  237. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  238. SUBJECTS AND METHODS
  239. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  240. Proximal Lacrimal Obstruction – A Review
  241. The superosmic phenomenon
  242. The Leicester Olfactometer
  243. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  244. ENT cases seen at a local ‘walk-in centre’: a one year review
  245. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  246. A brief history of olfaction and olfactometry
  247. The superosmic phenomenon
  248. Olfactory clearance: what time is needed in clinical practice?
  249. The Effect of Female Hormone Manipulation on Nasal Physiology
  250. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  251. R152: Olfactory Adaptation and Clearance in Clinical Practice
  252. Bronchiectasis and sino-nasal disease: a review
  253. What is the short term effect of perfumes on olfactory thresholds?
  254. Which variables matter in smell tests in the clinic?
  255. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  256. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  257. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  258. Comparison of Subjective Perception with Objective Measurement of Olfaction
  259. Response to Rachmanidou
  260. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  261. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  262. Do our Noses Lead Us Away from the Scent?
  263. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  264. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  265. Is there a role for more day-case septal surgery?
  266. Erratum
  267. Canalicular adenoma of the parotid gland
  268. Paediatric retropharyngeal abscess
  269. Which solvent for olfactory testing?
  270. Nasal physiological changes during pregnancy
  271. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  272. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  273. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  274. Subjects and methods
  275. Hyposmia